Jonathan M Miller,Kelley Poff,Jesse N Howell,Oscar K Serrano,Jim Kim,Alejandro Diez,Grace R Lyden,Bryn W Thompson,David Zaun,Jon J Snyder
{"title":"更新肾脏供者风险指数:去除供者种族和丙型肝炎病毒状态。","authors":"Jonathan M Miller,Kelley Poff,Jesse N Howell,Oscar K Serrano,Jim Kim,Alejandro Diez,Grace R Lyden,Bryn W Thompson,David Zaun,Jon J Snyder","doi":"10.1016/j.ajt.2025.01.015","DOIUrl":null,"url":null,"abstract":"This study reports the results of a recalculation of the kidney donor risk index (KDRI) formula requested by the Organ Procurement and Transplantation Network's Minority Affairs Committee to remove donor race and hepatitis C virus (HCV) status variables. The updated KDRI model was fit on adult, deceased donor, solitary kidney, first-time transplants from 2018 through 2021. Deceased donors from 2018 through 2021 were included in a counterfactual analysis to evaluate how the kidney donor profile index (KDPI) would change if race and HCV seropositivity were excluded. When recalculating the original KDRI models on 2018-2021 transplants, the donor Black race coefficient was only slightly lower (β = 0.18 in original model; β = 0.15 in 2018-2021 cohort), while the donor HCV seropositivity coefficient was substantially lower (β = 0.24 in original model; β = -0.04 in 2018-2021 cohort). Among Black donors, the probability of being classified as KDPI ≤ 20% increased and the probability of being classified as KDPI > 85% decreased notably when the Black race and HCV variables were removed from the model. Removing the donor race and donor HCV status variables in an updated KDRI model resulted in more racially equitable KDPI distributions.","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"24 1","pages":""},"PeriodicalIF":8.9000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Updating the kidney donor risk index: Removing donor race and hepatitis C virus status.\",\"authors\":\"Jonathan M Miller,Kelley Poff,Jesse N Howell,Oscar K Serrano,Jim Kim,Alejandro Diez,Grace R Lyden,Bryn W Thompson,David Zaun,Jon J Snyder\",\"doi\":\"10.1016/j.ajt.2025.01.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study reports the results of a recalculation of the kidney donor risk index (KDRI) formula requested by the Organ Procurement and Transplantation Network's Minority Affairs Committee to remove donor race and hepatitis C virus (HCV) status variables. The updated KDRI model was fit on adult, deceased donor, solitary kidney, first-time transplants from 2018 through 2021. Deceased donors from 2018 through 2021 were included in a counterfactual analysis to evaluate how the kidney donor profile index (KDPI) would change if race and HCV seropositivity were excluded. When recalculating the original KDRI models on 2018-2021 transplants, the donor Black race coefficient was only slightly lower (β = 0.18 in original model; β = 0.15 in 2018-2021 cohort), while the donor HCV seropositivity coefficient was substantially lower (β = 0.24 in original model; β = -0.04 in 2018-2021 cohort). Among Black donors, the probability of being classified as KDPI ≤ 20% increased and the probability of being classified as KDPI > 85% decreased notably when the Black race and HCV variables were removed from the model. Removing the donor race and donor HCV status variables in an updated KDRI model resulted in more racially equitable KDPI distributions.\",\"PeriodicalId\":123,\"journal\":{\"name\":\"American Journal of Transplantation\",\"volume\":\"24 1\",\"pages\":\"\"},\"PeriodicalIF\":8.9000,\"publicationDate\":\"2025-01-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ajt.2025.01.015\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajt.2025.01.015","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
Updating the kidney donor risk index: Removing donor race and hepatitis C virus status.
This study reports the results of a recalculation of the kidney donor risk index (KDRI) formula requested by the Organ Procurement and Transplantation Network's Minority Affairs Committee to remove donor race and hepatitis C virus (HCV) status variables. The updated KDRI model was fit on adult, deceased donor, solitary kidney, first-time transplants from 2018 through 2021. Deceased donors from 2018 through 2021 were included in a counterfactual analysis to evaluate how the kidney donor profile index (KDPI) would change if race and HCV seropositivity were excluded. When recalculating the original KDRI models on 2018-2021 transplants, the donor Black race coefficient was only slightly lower (β = 0.18 in original model; β = 0.15 in 2018-2021 cohort), while the donor HCV seropositivity coefficient was substantially lower (β = 0.24 in original model; β = -0.04 in 2018-2021 cohort). Among Black donors, the probability of being classified as KDPI ≤ 20% increased and the probability of being classified as KDPI > 85% decreased notably when the Black race and HCV variables were removed from the model. Removing the donor race and donor HCV status variables in an updated KDRI model resulted in more racially equitable KDPI distributions.
期刊介绍:
The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide.
The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.